NAD

TOP HEALTH NEWS: Better Aging May Soon Be Just A Pill Away

Retrieved on: 
Wednesday, March 15, 2023
Research, Radiation, Cancer, Harvard University, Longevity, Deficit spending, DNA, NAD, Ageing, Mouse, Cell, Water, Cellular senescence, Brain, Fountain of Youth, Younes Chaib, Old age, Computer mathematics, Science, Health, Sirtuin, Inflammation, SA, SSA, Fisetin, Nature Medicine, PMID, DNA repair, Nervous system, Scripps Research, DNA replication, Mayo Clinic, Oxidative stress, Vaccine, Amusement park, Hospital, Brightwell

IRVINE, Calif., March 14, 2023 /PRNewswire-PRWeb/ -- Regardless of whether the age-old myth of explorer Ponce de Leon searching for a Fountain of Youth is true, a new nutraceutical reaching the consumer market will mark a major milestone in the expedition towards improving the process of aging.

Key Points: 
  • Researchers at Irvine, California-based Seragon Biosciences have developed a proprietary set of molecules that have been found to slow aging and issues that arise with aging.
  • When integrated with a new controlled release technology, this new nutraceutical RESTORIN can attack the aging process at the cellular level.
  • Other studies have shown that using senolytics to reduce oxidative stress and cellular senescence in the brain can improve brain health.
  • "It's very thrilling to see aging research advancing ways to help people age slower, better, and healthier," he added.

Biotech labs TruDiagnostic and NADMED partner to launch novel NAD+ blood test in United States

Retrieved on: 
Wednesday, March 15, 2023
NADH, Partnership, Patient, Ageing, NAD, DSM-IV codes, Dementia, Cardiovascular disease, Entrepreneurship, Medical device, EU

LEXINGTON, Ky., March 15, 2023 /PRNewswire/ -- Doctors in the U.S. can now access a novel NAD+ blood diagnostic for their patients.

Key Points: 
  • LEXINGTON, Ky., March 15, 2023 /PRNewswire/ -- Doctors in the U.S. can now access a novel NAD+ blood diagnostic for their patients.
  • This is thanks to the launch of a new partnership with epigenetic laboratory TruDiagnostic and Finland-based NAD diagnostic company NADMED.
  • TruDiagnostic decided to partner with NADMED for their test accuracy and reliability.
  • The Q-NADMED Blood Kit is CE-marked for measuring NAD+ and NADH from a small blood sample for a range of clinical purposes.

NYC Based IV DRIPS Customized IV Hydration & Wellness, Announces Partnership with Neura Health

Retrieved on: 
Tuesday, March 14, 2023
DHE, Electrolyte, Patient, NAD, Nutrient, Antioxidant, Health, NeuraJet Neura Jet, Vomiting, Gold, Neuroscience Research Australia, Platinum, Vitamin, Wellness, Medical director, Dopamine, Headache, Nausea, MD, Brain, Migraine, NP, Hospital, Medical device, Aroma compound

NEW YORK, March 14, 2023 /PRNewswire-PRWeb/ -- IV DRIPS Customized IV Hydration & Wellness understands that true health starts with a body that is in balance. Now migraine patients in the midst of a debilitating attack can receive the same treatment that they would receive at the emergency room or migraine infusion center in the comfort and non-triggering environment of their home.

Key Points: 
  • NEW YORK, March 14, 2023 /PRNewswire-PRWeb/ -- IV DRIPS Customized IV Hydration & Wellness understands that true health starts with a body that is in balance.
  • IV DRIPS Customized IV Hydration & Wellness offers Neura Health drips with an effective, evidence-based infusion protocol, which is an efficient way to treat severe and long-lasting migraine attacks , including status migrainosus.
  • More About IV Drips Customized IV Hydration & Wellness:
    IV DRIPS Customized IV Hydration & Wellness was founded by Bracha L. Banayan, NP.
  • To find out more about IV Drips Customized IV Hydration & Wellness or to schedule concierge IV drip therapy across the country, please visit http://www.ivdrips.com or call 212-220-3957.

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2022 Results

Retrieved on: 
Wednesday, March 8, 2023
Research, Seniors, Genetics, Biotechnology, Health, Consumer, Pharmaceutical, General Health, Science, Science Advances, Sinopharm (company), Security (finance), Coronavirus Scientific Advisory Board, Webcast, G&A, Aging Cell, Brain, Acquisition, Neurodegenerative disease, Biomarker, Growth, NHNE, Replay, NAD, Partnership, GAAP, Annual report, Regulation, EBITDA, Investment, Tru, ChromaDex, COVID-19, Conference, WalletHub, R, Trial of the century, NR, Marketing, Ageing, NRH, Cryptocurrency, Pharmaceutical industry, Reinsurance, Video game, Dietary supplement, Fine chemical, Bookkeeping

ChromaDex Corp. (NASDAQ:CDXC) today announced fourth quarter and fiscal year 2022 financial results.

Key Points: 
  • ChromaDex Corp. (NASDAQ:CDXC) today announced fourth quarter and fiscal year 2022 financial results.
  • ChromaDex also holds two patents covering crystal forms of important intermediates in the production of NR Chloride, one of which was granted in 2022.
  • “ChromaDex proudly reported its best quarter ever, achieving $21.0 million in revenue in the fourth quarter, up 18% year-over-year and 23% sequentially,” said Rob Fried, ChromaDex Chief Executive Officer.
  • A live webcast will be held Wednesday, March 8, 2023 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss ChromaDex’s fourth quarter and fiscal year 2022 financial results and provide a general business update.

ChromaDex Announces Issuance of New U.S. Patent on Dihydronicotinamide Riboside (NRH) and Dihydronicotinic Acid Riboside (NARH), Further Solidifying ChromaDex as the Leader in the Nicotinamide Adenine Dinucleotide (NAD+) Precursor Space

Retrieved on: 
Wednesday, February 22, 2023
Biotechnology, Health, Patent Law, Professional Services, Pharmaceutical, NAD, Biochemistry, Mayo Clinic, Metabolism, Derivative, Ageing, ChromaDex, United States patent law, Journal, Frontiers, Patent, NAR, NRH, Molecular Metabolism, Attention, Macrophage, NADH, Pharmaceutical industry, Immunology

Niagen® is the sole active ingredient in ChromaDex’s flagship consumer product, Tru Niagen®, the most efficient and well-studied NAD+ precursor currently in the market.

Key Points: 
  • Niagen® is the sole active ingredient in ChromaDex’s flagship consumer product, Tru Niagen®, the most efficient and well-studied NAD+ precursor currently in the market.
  • “There is a great deal of interest in the scientific community around NRH,” said Rob Fried, CEO of ChromaDex.
  • The composition claims that have been granted are amongst the strongest patent claims that can be achieved for this NAD+ precursor.
  • U.S. Patent 11,584,770 is part of the patent family titled “Methods of Preparing Nicotinamide Riboside and Derivatives Thereof” exclusively licensed from Queen’s University Belfast.

Netherlands Diabetes Market Report 2023: Rising Prevalence of Obesity to Spur Future Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 15, 2023
Health, Diabetes, Roche, CDC National Prevention Information Network, CE marking, National Care Standards (Scotland), Obesity, Patient, Incidence, Region (Europe), Weight gain, Primary health care, NAD, Disease, Metabolic syndrome, CS, US, IDF, Prevalence, National Action, Overweight, Practitioner, Pharmaceutical industry, Medical device, Growth

The "Netherlands Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Netherlands Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Netherlands Diabetes Market will reach US$ 3.36 Billion in 2028 according to the publisher.
  • Netherlands' care for diabetes mainly concentrates on primary health care, with responsibility for most aspects of care in the hands of general practitioners.
  • The National Action program Diabetes (NAD) implementation in the Netherlands over the past decade has helped manage diabetes.

Manatt Expands Consumer Protection and Advertising Capabilities in D.C. With Accomplished Litigator

Retrieved on: 
Wednesday, February 1, 2023
Consulting, Other Professional Services, Legal, Professional Services, Manatt, Phelps & Phillips, Heel, Negotiation, Government, Stern, Community development, LLP, Intellectual property, Competition, Consumer protection, FTC, FCC, Real estate, Brandeis University, Eastern, NAD, ESG, Parent, Telecommunications, Marketing, Senior counsel, Columbia Law School, Special Immigrant Juvenile Status, AAA, American Arbitration Association, Communication, Advertising, JAMS, Property management, Charles Manatt

Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, announced today the addition of Consumer Protection and Advertising Partner Bezalel (Bez) Stern in the Firm’s Washington, D.C., office.

Key Points: 
  • Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, announced today the addition of Consumer Protection and Advertising Partner Bezalel (Bez) Stern in the Firm’s Washington, D.C., office.
  • “Our Consumer Protection and Advertising practice is a prime example of this since clients across our platform need a sophisticated understanding of the ever-evolving industry convergences and regulatory changes that shape virtually all related advertising activity.
  • Stern’s practice covers media and advertising, antitrust, communications and emerging technologies, class action defense, commercial litigation, and internal investigations.
  • He also served as a judicial law clerk to the Honorable Jonathan Goodman, Southern District of Florida.

Restore Hyper Wellness Expands New York City Storefronts to Broadway and Yorkville

Retrieved on: 
Tuesday, January 31, 2023
General Sports, Sports, Alternative Medicine, General Health, Health, Vitamins, Supplements, Fitness & Nutrition, Other Health, Cryotherapy, Entrepreneurship, NAD, IV, New Yorker, Education, Multimedia, Nightclub

Restore Hyper Wellness (Restore), a leading provider of proactive wellness services, announced further expansion into the New York City market.

Key Points: 
  • Restore Hyper Wellness (Restore), a leading provider of proactive wellness services, announced further expansion into the New York City market.
  • View the full release here: https://www.businesswire.com/news/home/20230131005373/en/
    Restore Hyper Wellness announces its expansion into the New York City market with two new locations in Yorkville and Broadway.
  • With 85% of consumers being willing to try a new Hyper Wellness activity, service, or product, Restore is focused on growing its footprint of wellness studios to make Hyper Wellness more accessible across the country.
  • 1 provider of cryotherapy in the U.S.
    With the opening of the Yorkville and Broadway studios, Restore expands its retail footprint to more than 185 locations in the U.S.
    For more information about Restore Hyper Wellness, its innovative modalities, a complete list of locations, and franchising opportunities, please visit restore.com .

MIRAILAB BIOSCIENCE Inc., the Leading Company in NMN Supplements Announces Health Mailing Kit Series

Retrieved on: 
Thursday, February 2, 2023
Research, Technology, Biotechnology, General Health, University, Health, Data Management, Science, Education, Artificial Intelligence, Postgraduate education, Diet, Stomach cancer, Smoking, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, Mitochondrion, Sugar, Ageing, Biomedicine, Breast cancer, Health status of Asian Americans, Cancer, Organelle, Dyslipidemia, Obesity, Effect, Drinking, Oxygen, Cell, NMN, University of Tokyo, Database, Nutrient, Diabetes, Mouth, Liver cancer, Prostate cancer, NAD, Risk, HQ, Hypertension, Outline of health sciences, Stroke, Lung cancer, Disease, Hiroshima University, Dementia, Quantification (science), Fats, Defense, Washington University in St. Louis, Mail order, Dietary supplement, Palladium, Copper, Nicotinamide mononucleotide

MIRAILAB BIOSCIENCE Inc. (HQ: Tokyo, Japan; CEO: Megumi Tanaka) is proud to announce our new product category: the health mailing kit series.

Key Points: 
  • MIRAILAB BIOSCIENCE Inc. (HQ: Tokyo, Japan; CEO: Megumi Tanaka) is proud to announce our new product category: the health mailing kit series.
  • Just swab your mouth, send us the sample and receive an analysis report informing you of your present and future health.
  • We were the first company in the world to market NMN supplements, and the pioneers of human clinical studies (“Assessment of Effects of Long-term Administration of Nicotinamide Mononucleotide (NMN)”, with Hiroshima University, the Graduate School of Biomedical & Health Sciences.)
  • Soon, we plan to add new products to our lineup of mailing kits and expand to new markets.

Seragon Announces RESTORIN®, the Most Advanced Anti-Aging Nutraceutical to Date

Retrieved on: 
Thursday, January 19, 2023
Neurodegeneration, Cell, Ageing, Journal of the ACM, Longevity, DNA, Harvard University, Mayo Clinic, NAD, Sirtuin, Protein, Diabetes, Research, Cancer, Scripps Research, Science, Vaccine

IRVINE, Calif., Jan. 19, 2023 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the launch of RESTORIN®, an advanced nutraceutical for healthy aging.

Key Points: 
  • IRVINE, Calif., Jan. 19, 2023 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the launch of RESTORIN®, an advanced nutraceutical for healthy aging.
  • For decades, the intricate nature of aging has left scientists with many stones unturned in the field of aging intervention.
  • The latest research has pinpointed senolytics and NAD+ as key technologies to address this challenge.
  • "We've been able to develop advanced forms of these molecules and a series of complex combinations to combat aging, using the best science we have.